ArticleNaunyn-Schmiedeberg's archives of pharmacology2026

METTL3/IGF2BP3 axis promotes gemcitabine resistance of pancreatic cancer cells through regulating USP33-mediated PAK1 deubiquitination and degradation.

Ling He et al.PubMed ↗Publisher ↗

No numbers read from the abstract.